Assessment of relative utility of underlying vs contributory causes of death by Batty, G. David et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Assessment of relative utility of underlying vs contributory
causes of death
Citation for published version:
Batty, GD, Gale, CR, Kivimäki, M & Bell, S 2019, 'Assessment of relative utility of underlying vs contributory
causes of death', JAMA network open, vol. 2, no. 7. https://doi.org/10.1001/jamanetworkopen.2019.8024
Digital Object Identifier (DOI):
10.1001/jamanetworkopen.2019.8024
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher's PDF, also known as Version of record
Published In:
JAMA network open
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 11. May. 2020
Original Investigation | Public Health
Assessment of Relative Utility of Underlying vs Contributory Causes
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G. David Batty, PhD, DSc; Catharine R. Gale, PhD; Mika Kivimäki, FMedSci; Steven Bell, PhD
Abstract
IMPORTANCE In etiological research, investigators using death certificate data have traditionally
extracted underlying cause of mortality alone. With multimorbidity being increasingly common,
more than one condition is often compatible with themanner of death. Using contributory cause
plus underlying cause would also have some analytical advantages, but their combined utility is
largely untested.
OBJECTIVE To compare the relative utility of cause of death data extracted from the underlying
cause field vs any location on the death certificate (underlying and contributing combined).
DESIGN, SETTING, AND PARTICIPANTS This study compares the association of 3 known risk
factors (cigarette smoking, low educational attainment, and hypertension) with health outcomes
based on where cause of death data appears on the death certificate in 2 prospective cohort study
collaborations (UK Biobank [N = 502655] and the Health Survey for England [15 studies] and the
Scottish Health Surveys [3 studies] [HSE-SHS; N = 193 873]). Data were collected in UK Biobank from
March 2006 to October 2010 and in HSE-SHS from January 1994 to December 2008. Data analysis
began in June 2018 and concluded in June 2019.
MAINOUTCOMESANDMEASURES Death from cardiovascular disease, cancer, dementia, and
injury. For each risk factor–mortality end point combination, a ratio of hazard ratios (RHR) was
computed by dividing the effect estimate for the underlying cause by the effect estimate for
anymention.
RESULTS In UK Biobank, there were 14 421 deaths (2.9%) during a mean (SD) of 6.99 (1.03) years of
follow up; in HSE-SHS, there were 21 314 deaths (11.0%) during a mean (SD) of 9.61 (4.44) years of
mortality surveillance. Established associations of risk factors with death outcomes were essentially
the same irrespective of placement of cause on the death certificate. Results from each studywere
mutually supportive. For having ever smoked cigarettes (vs never having smoked) in the UK Biobank,
the RHR for cardiovascular disease was 0.98 (95% CI, 0.87-1.10; P value for difference = .69); for
cancer, the RHRwas 0.99 (95% CI, 0.93-1.05; P value for difference = .69). In the HSE-SHS, the RHR
for cardiovascular disease was 0.94 (95% CI, 0.87-1.01; P value for difference = .09); for cancer, it
was 1.01 (95% CI, 0.94-1.10; P value for difference = .75).
CONCLUSIONS ANDRELEVANCE Risk factor–end point associations were not sensitive to the
placement of data on the death certificate. This has implications for the examination of the
association of risk factors with causes of death where there may be too few events to compute
reliable effect estimates based on the underlying field alone.
JAMA Network Open. 2019;2(7):e198024. doi:10.1001/jamanetworkopen.2019.8024
Key Points
Question What is the relative utility for
etiological research of using underlying
cause of mortality from death
certificates compared with using
any field?
Findings In 2 large cohort studies with
696 528 participants combined,
associations of known risk factors with
an array of death outcomes were
essentially the same, irrespective of the
location of the death data on the
certificate.
Meaning Our findings have implications
for risk factor–end point computations
in studies of rarer outcomes and those
with smaller sample sizes.
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Introduction
Death records have long been collected for the purposes of monitoring the health of populations,1,2
quantifying disease prognosis,3,4 and evaluating the impact of primary5 and secondary
interventions.6 To examine the influence of environmental and genetic characteristics on disease and
injury events, mortality records have also been extensively deployed in ecological,7 case-control,8
experimental,9 and, most frequently, prospective cohort studies.10-12 The use of death records as a
proxy for a health end point of interest is particularly important in contexts where linkages to other
electronic health registries, such as hospital data or cancer records, are not viable, and clinical
examination of studymembers is financially or logistically prohibitive. Linkage to death registers has
the further advantage of having no additional burden on study participants. Scientific endeavors in
which death data have been central to the understanding of disease etiology include the Framingham
studies, where hypertension was first shown to be a risk factor for heart disease13 and stroke14; the
original Whitehall study,15 where it was demonstrated that elevated blood glucose within the normal
rangewas related to vascular events; and the British Doctors Study16 where, perhapsmost famously,
smoking was first prospectively linked to lung cancer. There are numerous other examples.17
To accord with theWorld Health Organization guidelines,18 death certificates are formulated in
2 parts. For the purposes of epidemiological research, the underlying (ie, immediate or direct) cause
of death is almost exclusively extracted. Other diseases or injuries that contributed to the death but
were not directly implicated appear in another section of the certificate. However, in practice, this
contributory information is very rarely used.19 With multimorbidity being common in an era of
effective treatments, more than one condition can be compatible with themanner of death.20
Analyses that use only the underlying cause of deathmay therefore omit valuable information that is
readily available.
In estimating burden of disease, reliance on underlying cause compared with incorporating
contributory causes appears to lead to underestimates of the importance of several leading causes
of death.21 However, the impact for etiological research is largely unknown. In the only study of which
we are aware,22 investigators found the same predictive capacity for classic risk factors in analyses
featuring cardiovascular disease deaths irrespective of placement on the death certificate. No such
comparison was made for other important causes of death. Using data from the contributory field of
deathmay have the analytical advantage of facilitating investigation of the determinants of rarer
causes of death (eg, intentional injury23 and dementia24) where, particularly in smaller cohort
studies, a reliance on underlying cause alonemay result in too few events to facilitate statistical
computations. The value to investigators of larger studies of commonly occurring conditions might
be enhanced statistical precision.
Using data from 2 large cohort studies, we examined associations of 3 known risk factors with
major causes of death, including cancer, cardiovascular disease, injury, and dementia. To provide
findings of interest to a range of disciplines, we used physiological (hypertension25), psychosocial
(educational attainment26), and behavioral (cigarette smoking27,28) risk factors. Our aimwas to
examine if these risk factors had the samemagnitude of association with cause-specific mortality
when end point data were extracted from the underlying field alone vs the underlying and
contributory fields combined (ie, anymention).
Methods
Included Cohort Studies
We used data fromUK Biobank,29 a prospective cohort study, and a pooling of 18 identical cohort
studies from the Health Survey for England (15 studies) and the Scottish Health Surveys (3 studies)
(HSE-SHS).30-32 These studies were selected because they offer similar, standard processes for data
collection. Participants in both studies gave full informed consent. In the UK Biobank, ethical
approval was received from the NorthWest Multi-center Research Ethics Committee, and the
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research was carried out in accordance with the Declaration of Helsinki.33 In HSE-SHS, ethical
approval for data collection was granted by the London research ethics council or the local research
ethics councils. This study analyzed existing anonymized data, and therefore, no further ethical
approval was required. This report follows the Strengthening the Reporting of Observational Studies
in Epidemiology (STROBE) reporting guideline.
Baseline Data Collection
The sampling and protocols of these studies have been well described.29-32 In brief, baseline data
collection in the UK Biobank took place betweenMarch 2006 and October 2010 in research
assessment centers across the United Kingdom, with data collected on 502655 people aged 40 to
69 years (response proportion, 6%). Between January 1994 and December 2008, a total of 193 842
people aged 16 to 102 years (response proportion, 64%-78%) participated in HSE-SHS, with data
collection taking place exclusively in the home (Table).
Responses to history of cigarette smoking habits (ie, ever smoker vs never) and highest attained
educational qualification (ie, no university degree vsuniversity undergraduate degree) were
collapsed into binary categories for the purposes of presentation brevity. In UK Biobank, systolic and
diastolic blood pressuremeasurements were taken twicewhile the participant was seated using the
Omron HEM-7015IT digital blood pressure monitor (Omron Healthcare).20 Blood pressure in the
present analyses was based on the average of the 2measurements. In HSE-SHS, blood pressure was
measured using the Dinamap 8100 automated device (GE Critikon).34 Following a 5-minute seated
rest, 3 readings of systolic and diastolic blood pressure were taken from the right arm at 1-minute
intervals. Blood pressure used in the present analysis was based on themean of the second and third
measurement. We defined hypertension according to existing guidelines as systolic/diastolic blood
pressure of at least 140/90mmHg and/or use of antihypertensive medication.35
Ascertainment of Cause-SpecificMortality
Study participants were flagged using the procedures of the UK National Health Service (NHS)
Central Registry. Underlying and contributing deaths were classified according to the International
Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10)18 as follows:
attributable to (1) all cancers combined (codes C00-C97), (2) lung cancer (C34), (3) cardiovascular
disease (I20-5, I50, I60-70, I73, and I74), (4) coronary heart disease (I20-5), (5) cerebrovascular
disease (I60-9), (6) external causes (V01-Y99), and (7) dementia (F00-F02, F03, F05, F10, G30, G31,
I67 and A81).24 Where necessary, corresponding codes from earlier revisions of the ICDwere used.
The any mention category was a combination of the underlying and contributory cause of
death fields.
Table. Characteristics of StudyMembers in UK Biobank and HSE-SHS
Characteristic
No. (%)
UK Biobank HSE-SHS
Participants recruited, No.a 502 655 193 873
Women 273 472 (54.4) 106 469 (54.9)
Age at baseline,
mean (SD) [range], y
56.5 (8.1) [38-73] 46.8 (18.5) [16-102]
Ever smoked 225 896 (45.2) 98 581 (51.1)
No university education 331 298 (67.3) 147 353 (76.0)
Hypertension 282 637 (57.2) 43 428 (36.9)
Duration of mortality
surveillance, mean (SD), y
6.99 (1.03) 9.61 (4.44)
Death from any cause 14 421 (2.9) 21 314 (11.0)
Abbreviation: HSE-SHS, Health Survey for England and the Scottish
Health Surveys.
a Number of studymembers and events are higher in this Table than in the
survival analyses, which havemissing data.
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Statistical Analysis
Hazard ratios (HRs) and accompanying 95% CIs were computed using Cox regressionmodels36 and
adjusted for age and sex. In these survival analyses, we censored individuals according to the date of
death or the end of follow-up (February 22, 2016, for UK Biobank, February 14, 2011, for HSE, and
December 31, 2009, for SHS), whichever came first. For a summarymeasure of the difference
between the HRs based on the 2 approaches to classifying mortality, we computed a ratio of the HRs
(RHR) as has been used elsewhere.37,38 We also computed the P value for difference between
underlying vs anymention HRs for the 2 studies. To do so, we used the Fisher z score measure to test
for equality of HRs, with z calculated as the difference between the logarithms of the HRs (β1, β2)
divided by the square root of the sum of the square of their variances (SE12, SE22), where z follows a
normal distribution: z = (β1 − β2)/(SE12 + SE22).39 No prespecified level of statistical significance
was set, and all tests were 2-tailed. Analyses were conducted using Stata version 15 (Stata Corp) and
took place from June 2018 to June 2019.
Results
In the Table, we show the characteristics of studymembers in UK Biobank and HSE-SHS at baseline
and their mortality experience. The proportion of women in the baseline sample was similar in UK
Biobank (273 472 [54.4%]) and HSE-SHS (106 469 [54.9%]). The prevalence of people who reported
ever having smoked and thosewithout a university educationwas somewhat higher in HSE-SHS than
UK Biobank (smoking: 98 581 [51.1%] vs 225 896 [45.2%]; no university degree: 147 353 [76.0%] vs
331 298 [67.3%]), while hypertension was less common (43 428 [36.9%] vs 282 637 [57.2%]).
In UK Biobank there were 14 421 deaths among 502655 people (2.9%) during a mean (SD)
follow-up period of 6.99 (1.03) years, while in the pooling of HSE-SHS, a mean (SD) follow-up period
of 9.61 (4.44) years of mortality surveillance gave rise to 21 314 deaths among 193 873 individuals
(11.0%). In Figure 1, Figure 2, and Figure 3, we show numbers of deaths for eachmajor cause of
mortality as retrieved from the underlying cause field as well as in combination with the contributing
field (ie, anymention). The number of study participants and deaths in the sample used in the Figures
ismarginally lower than the full cohort owing to somemissing data for the exposures of interest. The
number of deaths in the any mention group was necessarily higher for all conditions, a differential
that was least pronounced for cancer, whichmay reflect dissemination of the primarymalignancy (ie,
underlying cause).
In Figure 1, we show the age-adjusted and sex-adjusted HRs for baseline cigarette smoking
status associated with deaths from cardiovascular disease, its different presentations (ie, coronary
heart disease and cerebrovascular disease), and all cancers combined. The expected associations
were apparent, such that ever having smoked cigarettes was associated with an elevated rate of
mortality from all conditions. Within studies, the size of the effect estimates was very similar,
irrespective of whether the underlying or anymention field was used, so that the RHRs all hovered
around unity (P value for difference .09). For example, in the UK Biobank, the RHR for
cardiovascular disease was 0.98 (95% CI, 0.87-1.10; P value for difference = .69); for cancer, the RHR
was 0.99 (95% CI, 0.93-1.05; P value for difference = .69). In the HSE-SHS, the RHR for
cardiovascular disease was 0.94 (95% CI, 0.87-1.01; P value for difference = .09); for cancer, it was
1.01 (95% CI, 0.94-1.10; P value for difference = .75). Similar observations were apparent for lung
cancer, which, owing to the strong association with smoking in both UK Biobank (underlying cause:
HR, 7.60; 95% CI, 6.50-8.88; any mention: HR, 7.84; 95% CI, 6.72-9.13) and HSE-SHS (underlying
cause: HR, 10.38; 95% CI, 8.14-13.23; anymention: HR, 9.04; 95% CI, 7.33-11.15) could not be
accommodated in the Figure alongside the expected weaker effect estimates for other outcomes.
Owing to the higher numbers of deaths in the anymention group, statistical precision was somewhat
higher, as evidenced by the tighter 95% CIs.
In Figure 2 we showHRs for the association of educational attainment with the samemortality
outcomes featured in Figure 1, with the addition of dementia and external causes. As anticipated, a
JAMANetworkOpen | Public Health Assessment of Relative Utility of Underlying vs Contributory Causes of Death
JAMA Network Open. 2019;2(7):e198024. doi:10.1001/jamanetworkopen.2019.8024 (Reprinted) July 31, 2019 4/11
Downloaded From: https://jamanetwork.com/ by a University of Edinburgh Library User  on 08/07/2019
more basic education, denoted by the absence of a university degree, was associated with an
increased risk of mortality from all featured causes of death. Themagnitude of these effect estimates
was similar within the studies irrespective of the position of cause on the death certificate; thus, the
RHRs ranged from0.73 (95% CI, 0.45-1.18) for dementia in UK Biobank to 1.30 (95% CI, 0.70-2.44)
for external causes in HSE-SHS, with a P value for difference > .20.
Last, in Figure 3 we depict the association of hypertension with mortality risk. People with
hypertension experienced elevated rates of death from cardiovascular disease compared with their
unaffected counterparts. Cross-study HRs were very similar with the RHRs all being close to unity
and the P values for difference all being nonsignificant at conventional levels. Thus, the RHRs for
cardiovascular disease in UK Biobank (1.04; 95% CI, 0.90-1.20; P value for difference = .60) and in
HSE-SHS (1.00; 95% CI, 0.89-1.13; P value for difference = .95) were very similar, as they were for its
subtypes of coronary heart disease (UK Biobank: RHR, 1.02; 95% CI, 0.86-1.20; P value for
difference = .86; HSE-SHS: RHR, 0.96; 95% CI, 0.83-1.12; P value for difference = .59), and
cerebrovascular disease (UK Biobank: RHR, 0.98; 95% CI, 0.75-1.29; P value for difference = .90;
HSE-SHS: RHR, 0.90; 95% CI, 0.73-1.12; P value for difference = .36).
Figure 1. Association of Smoking StatusWith Cause-Specific Mortality in the UK Biobank (N = 499 701) and the Health Survey for England
and Scottish Health Surveys (HSE-SHS; N = 193037)
P Value for
Difference
Lower
Risk
Higher
RiskOutcome
Coronary heart disease
.28Underlying cause only
Any mention
Cerebrovascular disease
.84Underlying cause only
No. of
Events
1642
2386
545
878
2224
3417
8227
8603
HR
(95% CI)
2.15 (1.93-2.39)
2.32 (2.12-2.54)
1.75 (1.47-2.09)
1.71 (1.49-1.97)
2.04 (1.87-2.24)
2.09 (1.94-2.25)
1.68 (1.60-1.75)
1.70 (1.62-1.77)
RHR
(95% CI)
0.93 (0.81-1.07)
1.02 (0.82-1.28)
0.98 (0.87-1.10)
0.99 (0.93-1.05)
Any mention
Underlying cause only .69
.69
Cardiovascular disease
Any mention
Cancer
Any mention
Underlying cause only
0 2.0 3.01.0 1.5 2.5
HR (95% CI)
0.5
UK BiobankA
P Value for
Difference
Lower
Risk
Higher
RiskOutcome
Coronary heart disease
.34Underlying cause only
Any mention
Cerebrovascular disease
.76Underlying cause only
No. of
Events
3556
5065
1467
2404
5071
8279
5491
6487
HR
(95% CI)
1.49 (1.38-1.60)
1.56 (1.47-1.65)
1.26 (1.13-1.41)
1.29 (1.19-1.40)
1.38 (1.30-1.46)
1.47 (1.40-1.54)
1.78 (1.68-1.89)
1.76 (1.66-1.85)
RHR
(95% CI)
0.96 (0.87-1.05)
0.98 (0.85-1.12)
0.94 (0.87-1.01)
1.01 (0.94-1.10)
Any mention
Underlying cause only .09
.75
Cardiovascular disease
Any mention
Cancer
Any mention
Underlying cause only
0 2.0 3.01.0 1.5 2.5
HR (95% CI)
0.5
HSE-SHSB
Shaded squares indicate the hazard ratios (HRs), and error bars denote the 95% CIs for
the association of smoking status with the risk of death from a range of diseases. The
reference group is never having smoked cigarettes. The ratio of hazard ratios (RHR)
summarizes the difference, with underlying cause as the reference group, between the
effect estimate for the outcome as ascertained from different locations on the death
certificate. The number of study participants and deaths in the sample used in this
survival analysis is marginally lower than the full cohort owing tomissing data for the
exposure of interest.
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Figure 2. Association of Educational Attainment with Cause-Specific Mortality in the UK Biobank (N = 492 513) and the Health Survey for England
and Scottish Health Surveys (HSE-SHS; N = 193 702)
P Value for
Difference
Lower
Risk
Higher
RiskOutcome
Coronary heart disease
.44Underlying cause only
Any mention
Cerebrovascular disease
.65Underlying cause only
No. of
Events
1599
2326
534
860
2167
3332
8081
1467
140
238
478
936
1554
8443
HR
(95% CI)
1.61 (1.43-1.81)
1.71 (1.54-1.89)
1.60 (1.30-1.99)
1.71 (1.45-2.05)
1.59 (1.44-1.77)
1.63 (1.50-1.78)
1.24 (1.18-1.30)
1.25 (1.19-1.32)
2.22 (1.93-2.56)
2.26 (1.97-2.60)
0.97 (0.67-1.40)
1.33 (0.98-1.82)
1.51 (1.23-1.86)
1.62 (1.39-1.89)
RHR
(95% CI)
0.94 (0.81-1.10)
0.94 (0.70-1.24)
0.98 (0.85-1.12)
0.99 (0.92-1.07)
0.98 (0.80-1.20)
0.73 (0.45-1.18)
0.93 (0.72-1.21)
Any mention
Underlying cause only .73
.83
.86
.20
.60
Cardiovascular disease
Any mention
Cancer
Any mention
Underlying cause only
Lung cancer
Underlying cause only
Any mention
Underlying cause only
Dementia
Any mention
External causes
Any mention
Underlying cause only
0 2.0 3.01.0 1.5 2.5
HR (95% CI)
0.5
UK BiobankA
P Value for
Difference
Lower
Risk
Higher
RiskOutcome
Coronary heart disease
.50Underlying cause only
Any mention
Cerebrovascular disease
.59Underlying cause only
No. of
Events
3555
5065
1468
2402
5073
8279
5498
1018
448
1329
107
872
1220
6494
HR
(95% CI)
1.50 (1.32-1.71)
1.59 (1.43-1.78)
1.48 (1.19-1.83)
1.37 (1.17-1.61)
1.51 (1.35-1.68)
1.50 (1.37-1.63)
1.37 (1.25-1.50)
1.40 (1.28-1.53)
2.49 (1.90-3.28)
2.51 (1.96-3.22)
1.56 (1.02-2.37)
1.33 (1.07-1.67)
2.02 (1.13-3.62)
1.55 (1.22-1.96)
RHR
(95% CI)
0.94 (0.79-1.12)
1.08 (0.82-1.40)
1.01 (0.87-1.16)
0.98 (0.86-1.11)
0.99 (0.69-1.44)
1.17 (0.73-1.88)
1.30 (0.70-2.44)
Any mention
Underlying cause only .93
.75
.97
.52
.41
Cardiovascular disease
Any mention
Cancer
Any mention
Underlying cause only
Lung cancer
Underlying cause only
Any mention
Underlying cause only
Dementia
Any mention
External causes
Any mention
Underlying cause only
0 2.0 3.01.0 1.5 2.5
HR (95% CI)
0.5
HSE-SHSB
Shaded squares indicate the hazard ratios (HRs), and error bars denote the 95% CI for
the association of educational attainment with the risk of death from a range of long-
term diseases and injury. The reference group is having a university undergraduate
degree or higher. The ratio of hazard ratios (RHR) summarizes the difference, with
underlying cause as the reference group, between the effect estimate for the outcome
as ascertained from different locations on the death certificate. The number of study
participants and deaths in the sample used in this survival analysis is marginally lower
than the full cohort owing tomissing data for the exposure of interest.
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Discussion
In this study, known associations of risk factors with an array of health end points were essentially the
same irrespective of whether death data were drawn from the underlying cause field on the death
certificate or a combination of underlying and contributory categories. These observations were
confirmed in independent data sets. The anymention field is, as described, a combination of
underlying and contributory fields. For outcomes where there is a small difference in absolute
numbers of cases between these groups, such as cancer, the HRs based on analyses of each group
will necessarily be nearly identical. More surprising is the similarity in effect estimates where
discordance in the number of events is high, that is, for all other outcomes featured herein:
cardiovascular disease (and the different presentations it comprises), dementia, and external causes.
An implication of our findings is that using the contributory field alongside the underlying cause field
may have the advantage of facilitating investigation of risk factors for the occurrence of rarer forms
of death where, particularly in smaller cohort studies, theremay be too few events to compute effect
estimates using the underlying field alone. The value in larger studies, such as those used here,might
bemarginally improved statistical precision.
As described, we were able to identify only 1 other study that has systematically compared the
utility for etiological research of using a combination of the underlying cause and contributory cause
fields on death certificates with using the underlying cause filed alone.22 Usingmortality records
from theWestern Electric Study, the 5 risk factors examined—age, systolic blood pressure, blood
cholesterol, bodymass index, and cigarette smoking status—revealed near-identical HRs for the
Figure 3. Association of Hypertension StatusWith Cardiovascular DiseaseMortality in the UK Biobank (N = 492 513) and the Health Survey for England
and Scottish Health Surveys (HSE-SHS; N = 117 606)
P Value for
Difference
Lower
Risk
Higher
RiskOutcome
Coronary heart disease
.86Underlying cause only
Any mention
Cerebrovascular disease
.90Underlying cause only
No. of
Events
1606
2336
541
872
2179
3353
HR
(95% CI)
1.94 (1.70-2.21)
1.91 (1.71-2.12)
1.72 (1.39-2.12)
1.75 (1.48-2.07)
1.89 (1.69-2.11)
1.82 (1.67-1.99)
RHR
(95% CI)
1.02 (0.86-1.20)
0.98 (0.75-1.29)
1.04 (0.90-1.20)
Any mention
Underlying cause only .60
Cardiovascular disease
Any mention
0 2.0 3.01.0 1.5 2.50.5
UK BiobankA
P Value for
Difference
Lower
Risk
Higher
RiskOutcome
Coronary heart disease
.59Underlying cause only
Any mention
Cerebrovascular disease
.36Underlying cause only
No. of
Events
2199
3162
938
1512
3178
5174
HR
(95% CI)
2.06 (1.84-2.31)
2.15 (1.95-2.37)
1.48 (1.25-1.76)
1.64 (1.43-1.88)
1.93 (1.76-2.13)
1.93 (1.79-2.08)
RHR
(95% CI)
0.96 (0.83-1.12)
0.90 (0.73-1.12)
1.00 (0.89-1.13)
Any mention
Underlying cause only .95
Cardiovascular disease
Any mention
0 2.0 3.01.0 1.5 2.50.5
HSE-SHSB
HR (95% CI)
HR (95% CI)
Shaded squares indicate the hazard ratios (HRs), and error bars denote the 95% CIs for
the association of hypertension status with the risk of death from different presentations
of cardiovascular disease. The reference group is not having hypertension. The ratio of
hazard ratios (RHR) summarizes the difference, with underlying cause as the reference
group, between the effect estimate for the outcome as ascertained from different
locations on the death certificate. The number of study participants and deaths in the
sample used in this survival analysis is marginally lower than the full cohort owing to
missing data for the exposure of interest.
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association of these risk factors with cardiovascular disease mortality for the 2 sources of the
mortality outcome. There are also examples of investigators who have followed this analytical
process but reported their findings qualitatively only. Thus, in our previous work,40 psychological
distress was associated with an elevated risk of death as drawn from themajor ICD-10 chapters,
whether extracted from underlying cause on the death certificate or in combination with
contributory cause. Similar results were seen when the predictive capacity of alcohol intake and
obesity for liver disease was assessed,41 when pulmonary function was associated with dementia
death,42 and when we investigated the association of neuroticismwith mortality from
various causes.43
Strengths and Limitations
While the present study has strengths—its relative novelty and the comparison of results across large,
well-powered studies—there are inevitably some shortcomings. Biomedical data, while available for
analyses in HSE-SHS, were not available in UK Biobank at the time of analyses. It has therefore not
been possible to compare the association of cholesterol fractions, glycated hemoglobin, and
inflammatory markers, all linked etiologically with cardiovascular disease,44 with mortality across
different placements of cause of death on the death certificate. Based on the present results, we
think it is unlikely that these risk indices will yield results very different from the patterns described
here. Second, our exposure variables are known to be associated with themajor stroke subtypes (ie,
ischemic and hemorrhagic); however, on UK death certificates stroke subtype is usually too ill
defined to be useful.45 Therefore, we were not able to run such analyses. Third, while UK Biobank is
undoubtedly rare in its scale and broad in its content, it had an unconventionally low response to its
baseline survey of approximately 6%. This has prompted debates about the generalizability of its
findings.46-49 This notwithstanding, HSE-SHS, an independent data set, had response rates in the
normal range (64%-78%).50
Conclusions
Risk factor–end point associations were not sensitive to the placement of mortality data on the death
certificate. Using cause of death positioned anywhere on a death certificatemay have the advantage
of facilitating investigation of risk factors for the occurrence of rarer forms of death where,
particularly in smaller cohort studies, there may be too few events to facilitate effect estimate
computations using the underlying field alone.
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